Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Seagen Inc
(NQ:
SGEN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 13, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Seagen Inc
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Seagen Tukysa Maintains Survival Benefit, Delays Cancer Progression In The Brain In Breast Cancer Patients
December 09, 2021
Seagen Inc (NASDAQ: SGEN) has revealed new data from exploratory analyses from the HER2CLIMB trial of Tukysa (tucatinib) combined with trastuzumab &...
Via
Benzinga
Why This Investor Is Selling His Seagen Shares
December 06, 2021
Having fallen more than 22% over the last month, Seagen Inc (NASDAQ: SGEN) shares are now trading down about 15% year-to-date. With Seagen stock seemingly stuck in a downtrend,...
Via
Benzinga
5 Stocks Insiders Are Selling
December 03, 2021
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...
Via
Benzinga
Investing $100,000 Into These 2 Stocks 10 Years Ago Would Have Made You a Millionaire Today
November 22, 2021
And doing so wouldn't have involved gambling with your portfolio, either.
Via
The Motley Fool
Where Seagen Stands With Analysts
November 09, 2021
Over the past 3 months, 6 analysts have published their opinion on Seagen (NASDAQ:
Via
Benzinga
Expert Ratings For Seagen
October 29, 2021
Seagen (NASDAQ:SGEN) has observed the following analyst ratings within the...
Via
Benzinga
Earnings Scheduled For October 28, 2021
October 28, 2021
Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million. •...
Via
Benzinga
Earnings Scheduled For July 29, 2021
July 29, 2021
Companies Reporting Before The Bell • Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter. • Cohen & Co (AMEX:COHN) is...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2021
November 09, 2021
Upgrades JP Morgan upgraded the previous rating for New Relic Inc (NYSE:
Via
Benzinga
Notable Seagen Insider Trades $7.4M In Company Stock
November 04, 2021
Jean I Liu, Gc/EVP And Leg Afairs at Seagen (NASDAQ:SGEN), made a large buy and sell of company shares on November 1, according to a new SEC filing. What Happened: A Form 4 filing...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
CNBC's Final Trades: Seagen, Dollar Tree And This Pharma Major
November 04, 2021
On CNBC’s “Halftime Report Final Trades,&rd...
Via
Benzinga
Notable Seagen Insider Trades $7.4M In Company Stock
November 03, 2021
Todd E Simpson, Chief Financial Officer at Seagen (NASDAQ:SGEN), made a large buy and sell of company shares on October 29, according to a new SEC filing. What Happened: A Form 4...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
October 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Gilead, Merck to Study Trodelvy-Keytruda Combo For Breast Cancer Gilead, Inc...
Via
Benzinga
Seattle Genetics (SGEN) Q3 2021 Earnings Call Transcript
October 29, 2021
SGEN earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Seattle Genetics's Earnings Outlook
October 27, 2021
Seattle Genetics (NASDAQ:SGEN) is set to give its latest quarterly earnings report on Thursday, 2021-10-28. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
October 27, 2021
Raymond James raised Alphabet Inc. (NASDAQ:GOOGL
Via
Benzinga
2 Stocks That Have Doubled the S&P 500's Returns Over the Past 5 Years and Could Still Go Higher
October 22, 2021
These companies just keep on growing.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Health Care Sector Appears to Be a Drag on Positive UnitedHealth Earnings
October 15, 2021
Stock futures were pointing to a higher open even before Goldman Sachs (NYSE: GS) reported better than expected earnings. Goldman rose 2.25% before the open helping to...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
October 01, 2021
Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned. Four new...
Via
Benzinga
A Bullish Sign Appears On Seagen's Chart
September 30, 2021
If history is any guide, there may be good fortune ahead for shares of Seagen(NASDAQ:SGEN). A so-called "golden cross" has formed on its chart and, not surprisingly,...
Via
Benzinga
Why Genmab's Stock Is Trading Higher Today
September 21, 2021
Genmab A/S (NASDAQ:GMAB) shares are trading higher after the company, along with Seagen Inc. (NASDAQ: SGEN), announced the FDA has granted accelerated approval to...
Via
Benzinga
Exposures
Product Safety
Why Seagen's Stock Is Trading Higher Today
September 21, 2021
Seagen (NASDAQ:SGEN) shares are trading higher after the company, along with Genmab A/S (NASDAQ: GMAB), announced the FDA has granted accelerated approval to TIVDAKTM...
Via
Benzinga
Exposures
Product Safety
FDA Gives Accelerated Approval to Seagen - Genmab's ADC In Cervical Cancer
September 21, 2021
The FDA handed an accelerated approval to Seagen Inc (NASDAQ: SGEN) and Genmab A/S’ (NASDAQ: GMAB) Tivdak (tisotumab vedotin-tftv, or TV). The...
Via
Benzinga
Exposures
Product Safety
Seagen, Genmab Present Tisotumab Vedotin Combo Data In Cervical Cancer
September 20, 2021
Seagen Inc (NASDAQ: SGEN) and Genmab A/S (NASDAQ: GMAB) have interim data from two Phase 1b/2 innovaTV 205 trial cohorts. The trial is evaluating its...
Via
Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics...
Via
Benzinga
Exposures
COVID-19
A Look Into Seagen's Price Over Earnings
August 24, 2021
In the current market session, Seagen Inc. (NASDAQ:SGEN) is trading at $165.17, after a 0.24% drop. However, over the past month, the stock increased by 14.36%, and...
Via
Benzinga
Week In Review: RemeGen Out-Licenses Rights For HER2 ADC To Seagen In $2.6 Billion Deal
August 14, 2021
Yantai's RemeGen out-licensed global rights (ex-Asia) for its novel HER2-targeted ADC to Seagen in a $2.6 billion deal. Seagen, an antibody conjugate company, will pay $200 million upfront and up to...
Via
Talk Markets
Seagen Bets On China's ADC In $2.6B Cancer Deal
August 09, 2021
Seagen Inc (NASDAQ: SGEN) and RemeGen Co Ltd have entered into an exclusive worldwide licensing agreement to develop and commercialize disitamab vedotin...
Via
Benzinga
Seattle Genetics (SGEN) Q2 2021 Earnings Call Transcript
July 30, 2021
SGEN earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.